The Board approved the audited financial results for the quarter and financial year ended 31st March 2026. No dividend was recommended.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.4 pts less than Nifty Microcap 250 and 2.5 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Chennai Meenakshi Multispeciality Hospital reported total income of Rs 3,815.66 lakhs for FY2026, up 7% from Rs 3,567.21 lakhs in the prior year. However, the company recorded a net loss of Rs 111.72 lakhs (vs loss of Rs 137.37 lakhs in FY2025), showing a 19% improvement in losses. The company swung to a small profit in Q4 (Rs 0.22 lakh PBT vs Rs 31.83 lakh in Q4 FY2025). EBITDA margin compressed from 9.8% to 8.2% year-on-year. No dividend was declared. The statutory auditors issued an unmodified opinion. However, the balance sheet shows a critical concern: total equity stands at negative Rs 307.54 lakhs (negative reserves of Rs 1,054.43 lakhs), indicating that liabilities exceed assets by Rs 307.54 lakhs.
The company has negative net worth and faces significant financial stress despite marginal improvement in operating performance. The stock carries high risk due to negative equity and ongoing losses, though the auditors gave a clean opinion.